Pharmacy Times®
Specialty Pharmacy Times
  • Keeping an Eye on Hepatitis C Virus Drug Approvals
  • Community Specialty Pharmacy: The Time Is Now!
  • Specialty Pipeline Highlights
  • Evaluating and Elevating Specialty Pharmacists Through Certification
  • How Will Specialty Pharmacy Be Affected By Cost Containment?
  • Psoriatric Arthritis: An Overview
Imaging Technology May Help Detect Cancer Earlier
Davy James, Associate Editor
Nanotechnology and shortwave infrared light reveals small tumors and cardiovascular lesions deep inside body.
FDA Accepts Application for Pediatric Combo Vaccine
Hexavalent vaccine protects against diphtheria, tetanus, pertussis, polio, invasive disease caused by Haemophilus influenzae type b, and hepatitis B.
Treatment for Rare Hemophilia Approved by FDA
Davy James, Associate Editor
Obizur treats a bleeding disorder caused by the development of antibodies directed against a protein that inhibits blood clotting.
Cyramza by Eli Lilly
Michael R. Page, PharmD, RPh
Cyramza (ramucirumab) was approved for treatment of patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma after disease progression.
Zontivity by Merck and Co, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Zontivity (voraxapar) for prevention of thrombotic cardiovascular events in patients with peripheral artery disease or a history of myocardial infarction.
Featured Video
Challenges Ahead for Specialty Pharmacy
Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Conference Calendar
â—„        October 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.